Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainFATC

MTOR PRKDC

3.65e-0451142PF02260
DomainFAT

MTOR PRKDC

5.45e-0461142PS51189
DomainFATC

MTOR PRKDC

5.45e-0461142PS51190
DomainFAT

MTOR PRKDC

5.45e-0461142PF02259
DomainPIK-rel_kinase_FAT

MTOR PRKDC

5.45e-0461142IPR003151
DomainFATC_dom

MTOR PRKDC

5.45e-0461142IPR003152
DomainPIK_FAT

MTOR PRKDC

5.45e-0461142IPR014009
DomainFATC

MTOR PRKDC

5.45e-0461142SM01343
DomainCarboxylesterase_B_AS

CES1 CES3

1.01e-0381142IPR019826
DomainCARBOXYLESTERASE_B_1

CES1 CES3

1.01e-0381142PS00122
DomainARM-type_fold

KPNA4 MYBBP1A UBR4 LYST UPF2 MTOR CAB39L PRKDC

1.13e-033391148IPR016024
DomainMyosin_head_motor_dom

MYH1 MYH4 MYO9A

1.60e-03381143IPR001609
DomainMYOSIN_MOTOR

MYH1 MYH4 MYO9A

1.60e-03381143PS51456
DomainMyosin_head

MYH1 MYH4 MYO9A

1.60e-03381143PF00063
DomainMYSc

MYH1 MYH4 MYO9A

1.60e-03381143SM00242
DomainCENPB

TIGD4 JRK

2.34e-03121142SM00674
DomainDDE_1

TIGD4 JRK

2.34e-03121142PF03184
DomainDDE_SF_endonuclease_dom

TIGD4 JRK

2.34e-03121142IPR004875
DomainHTH_CENPB

TIGD4 JRK

2.76e-03131142PS51253
DomainHTH_CenpB_DNA-bd_dom

TIGD4 JRK

2.76e-03131142IPR006600
DomainCARBOXYLESTERASE_B_2

CES1 CES3

3.20e-03141142PS00941
DomainCOesterase

CES1 CES3

3.20e-03141142PF00135
DomainCarbesteraseB

CES1 CES3

3.20e-03141142IPR002018
DomainPI3/4_kinase_CS

MTOR PRKDC

3.68e-03151142IPR018936
DomainMyosin_N

MYH1 MYH4

3.68e-03151142PF02736
DomainMyosin_N

MYH1 MYH4

3.68e-03151142IPR004009
Domain-

MTOR PRKDC

4.19e-031611421.10.1070.11
DomainPI3Kc

MTOR PRKDC

4.19e-03161142SM00146
DomainMyosin_tail_1

MYH1 MYH4

5.30e-03181142PF01576
DomainMyosin_tail

MYH1 MYH4

5.30e-03181142IPR002928
DomainPI3_PI4_kinase

MTOR PRKDC

5.30e-03181142PF00454
DomainPI3_4_KINASE_1

MTOR PRKDC

5.30e-03181142PS00915
DomainPI3_4_KINASE_2

MTOR PRKDC

5.30e-03181142PS00916
DomainPI3/4_kinase_cat_dom

MTOR PRKDC

5.30e-03181142IPR000403
DomainPI3_4_KINASE_3

MTOR PRKDC

5.30e-03181142PS50290
DomainMyosin-like_IQ_dom

MYH1 MYH4

5.90e-03191142IPR027401
Domain-

MYH1 MYH4

5.90e-031911424.10.270.10
Domain-

ABHD12B CES1 LIPK CES3

6.10e-0311911443.40.50.1820
DomainAB_hydrolase

ABHD12B CES1 LIPK CES3

6.10e-031191144IPR029058
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

KPNA4 MYH1 MYH4 MYBBP1A DENND4A HSPA4L CES1 SIPA1L3 UBR4 CCDC50 HMGB3 LYST NUP205 XRN1 CES3 ALCAM PRKDC JAKMIP1 SLC25A31 RPL18A

8.37e-0814421182035575683
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

MYBBP1A FMR1 HSPA4L TEX2 UBR4 NUP214 F5 PHKB NAA35 DZIP3 MIOS TLN2

8.47e-084751181231040226
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

KPNA4 ERCC6 HSPA4L RBM33 SPEG CARMIL1 NUP214 CABLES1 FBXO22 DNAH12 CNOT1 TBL2

1.38e-074971181236774506
Pubmed

Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.

MYBBP1A UBR4 DNAJB4 CCDC50 HMGB3 NUP214 IDE IFIT1 LGALS3 NUP205 NUDT5 ZC2HC1A MTOR ALCAM PRKDC CNOT1 PALLD TBL2 RPL18A

1.78e-0713671181932687490
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

ARHGAP32 HAUS6 CARMIL1 SIPA1L3 DYRK1A UBAP1 CCDC50 NUP205 PHKB NUDT5 ZC2HC1A KIAA1217 XRN1 CNOT1 FHIP2B

2.15e-078531181528718761
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

ARHGAP32 WDR64 FMR1 UBR4 IDE IFIT1 YEATS2 RAB3GAP1 BNIP3 DNAH12 CNOT1 TBL2 FHIP2B

2.82e-076381181331182584
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

MYH4 MYBBP1A PHKB NBAS MTOR XRN1 PRKDC CNOT1

4.77e-07202118833005030
Pubmed

A High-Density Human Mitochondrial Proximity Interaction Network.

MYBBP1A MOSPD2 FMR1 HSPA4L RBM33 TEX2 UBR4 IDE IFIT1 PIKFYVE NBAS RAB3GAP1 BNIP3 UPF2 KIAA1217 GHITM FASTKD3 TBL2 RPL18A

6.97e-0714961181932877691
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

ARHGAP32 MYBBP1A FMR1 SIPA1L3 UBR4 HECTD4 DYRK1A ZC2HC1A MTOR KIAA1217 DZIP3 MIOS TLN2 JAKMIP1 CNOT1

9.85e-079631181528671696
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

MOSPD2 RBM33 TEX2 UBAP1 CCDC50 NUP214 PIKFYVE YEATS2 NBAS NUDT5 TPX2 XRN1 MIOS

1.33e-067331181334672954
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

MYH1 MYH4 POLA1 UBR4 TIGD4 CABLES1 NUP205 KY TBC1D14 PRKDC JAKMIP1 ARHGAP20 CNOT1

1.39e-067361181329676528
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

MYBBP1A HSPA4L RBM33 POLA1 UBR4 DNAJB4 NUP214 NUP205 MTOR PRKDC CNOT1 RPL18A

1.91e-066381181233239621
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

KPNA4 HAUS6 MYBBP1A CARMIL1 SIPA1L3 DNAJB4 NUP214 IDE PHKB NBAS NUDT5 KAT8 TPX2 TLN2 PRKDC CNOT1

1.92e-0611551181620360068
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

MYBBP1A ERCC6 FMR1 NUP205 UPF2 TPX2 XRN1 MIOS PRKDC CNOT1 TBL2 NOL8 RPL18A

1.95e-067591181335915203
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

KPNA4 MYH1 RBM33 POLA1 CARMIL1 HMGB3 UPF2 MTOR CAB39L PALLD RPL18A

2.36e-065381181128524877
Pubmed

Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.

ARHGAP32 TEX2 CABLES1 PIKFYVE NBAS NAA35 UPF2 CNOT1

2.43e-06251118829778605
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

HAUS6 MYBBP1A CARMIL1 CCDC50 NUP214 YEATS2 NUDT5 KIAA1217 TPX2 XRN1 PRKDC PALLD NOL8 RPL18A

3.62e-069341181433916271
Pubmed

KAP1 facilitates reinstatement of heterochromatin after DNA replication.

KPNA4 MYBBP1A POLA1 UBR4 NUP205 NBAS RAB3GAP1 UPF2 MTOR PRKDC PRPF39 CNOT1

5.21e-067041181229955894
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ARHGAP32 HAUS6 MYBBP1A HSPA4L MYO9A CARMIL1 NUP214 NUDT5 XRN1 PRKDC CNOT1 PALLD

5.51e-067081181239231216
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

ARHGAP32 MYBBP1A FMR1 HSPA4L MYO9A CARMIL1 SIPA1L3 DYRK1A PHKB ZC2HC1A UPF2 KIAA1217 XRN1 MIOS TLN2 CNOT1 RPL18A

6.93e-0614311181737142655
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

ARHGAP32 DENND4A MYO9A TEX2 CARMIL1 SIPA1L3 DYRK1A PRAG1 LYST MTOR KIAA1217 XRN1 PALLD

7.63e-068611181336931259
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

KPNA4 FMR1 TEX2 DNAJB4 NUP214 TEF IFIT1 LGALS3 NUP205 SCMH1 JRK TPX2

1.04e-057541181235906200
Pubmed

Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.

KPNA4 HAUS6 SLC26A2 POLA1 UBR4 DYRK1A CCDC50 NUP214 NUP205 NBAS NAA35 RAB3GAP1 UPF2 XRN1 NDUFAF6 CNOT1

1.10e-0513271181632694731
Pubmed

Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.

MTOR PRKDC

1.14e-052118227235137
Pubmed

An immunocompromised murine model of chronic Bartonella infection.

LYST PRKDC

1.14e-052118220395436
Pubmed

Dysregulation of FMRP/mTOR Signaling Cascade in Hypoxic-Ischemic Injury of Premature Human Brain.

FMR1 MTOR

1.14e-052118226239490
Pubmed

Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice.

LYST PRKDC

1.14e-05211829234770
Pubmed

Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice.

LYST PRKDC

1.14e-052118217392156
Pubmed

Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice.

TEF JRK

1.14e-05211827550318
Pubmed

DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer.

MTOR PRKDC

1.14e-052118232209447
Pubmed

Signs and lesions of experimental Sendai virus infection in two genetically distinct strains of SCID/beige mice.

LYST PRKDC

1.14e-05211828140728
Pubmed

Growth and muscle defects in mice lacking adult myosin heavy chain genes.

MYH1 MYH4

1.14e-05211829382868
Pubmed

Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.

MYH1 MYH4

1.14e-052118211150240
Pubmed

Spontaneous and experimental infections in scid and scid/beige mice.

LYST PRKDC

1.14e-05211828320959
Pubmed

Gender and cell-type-specific effects of the transcription-coupled repair protein, ERCC6/CSB, on repeat expansion in a mouse model of the fragile X-related disorders.

ERCC6 FMR1

1.14e-052118224352881
Pubmed

ALK mutants in the kinase domain exhibit altered kinase activity and differential sensitivity to small molecule ALK inhibitors.

LYST PRKDC

1.14e-052118219249873
Pubmed

Studies of virus-induced myocardial injury in mice: value of the scid mutation on different genetic backgrounds and combined with other mutations.

LYST PRKDC

1.14e-05211828391609
Pubmed

Murine granulated metrial gland cell population in beige (bg/bg) and SCID (scid/scid) genotypes.

LYST PRKDC

1.14e-05211828075241
Pubmed

SCID-bg mice as xenograft recipients.

LYST PRKDC

1.14e-05211829175014
Pubmed

Comparison of susceptibility of inbred and outbred infant mice to Escherichia coli heat-stable enterotoxin STa.

LYST PRKDC

1.14e-05211821639480
Pubmed

Identification of a novel intracellular cholesteryl ester hydrolase (carboxylesterase 3) in human macrophages: compensatory increase in its expression after carboxylesterase 1 silencing.

CES1 CES3

1.14e-052118222700792
Pubmed

Translocation of bacteria from the gastrointestinal tract in immunodeficient mice.

LYST PRKDC

1.14e-05211828709573
Pubmed

Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals.

LYST PRKDC

1.14e-05211828962121
Pubmed

Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.

LYST PRKDC

1.14e-052118223094018
Pubmed

Palladin Is a Neuron-Specific Translational Target of mTOR Signaling That Regulates Axon Morphogenesis.

MTOR PALLD

1.14e-052118229712777
Pubmed

Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. Brief report.

LYST PRKDC

1.14e-05211828267959
Pubmed

FAN1 protects against repeat expansions in a Fragile X mouse model.

FMR1 FAN1

1.14e-052118229990673
Pubmed

The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model.

LYST PRKDC

1.14e-052118220739949
Pubmed

Infection of the laboratory mouse with the intracellular pathogen Ehrlichia chaffeensis.

LYST PRKDC

1.14e-05211829673277
Pubmed

Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation.

LYST PRKDC

1.14e-05211828418200
Pubmed

Mycobacterium avium subspecies paratuberculosis triggers intestinal pathophysiologic changes in beige/scid mice.

LYST PRKDC

1.14e-052118211924817
Pubmed

Evaluation of three lines of immunodeficient mice for the study of spontaneous metastatic tumors.

LYST PRKDC

1.14e-052118210225324
Pubmed

Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice.

MYH1 MYH4

1.14e-052118211744674
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

HAUS6 DYRK1A HMGB3 F5 PHKB NUDT5 KAT8 TPX2 XRN1 DZIP3 CNOT1

1.31e-056451181125281560
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

MYBBP1A ERCC6 MYO9A POLA1 UBR4 NUP214 NUP205 NAA35 RAB3GAP1 FBXO22 ZC2HC1A UPF2 XRN1 PRKDC PALLD RPL18A

1.40e-0513531181629467282
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

MYBBP1A FMR1 POLA1 UBR4 NUP214 NUP205 MTOR XRN1 PRKDC CNOT1 RPL18A

1.46e-056531181122586326
Pubmed

Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.

HAUS6 MYBBP1A UBR4 NUP214 NUP205 FBXO22 XRN1 PRKDC CNOT1 PALLD

1.48e-055341181035032548
Pubmed

Network organization of the human autophagy system.

MYH4 FMR1 NUP205 RAB3GAP1 MTOR DZIP3 CAB39L PRKDC TBL2

1.92e-05437118920562859
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

MYBBP1A FMR1 HSPA4L HECTD4 DYRK1A NUP214 NUP205 TPX2 MIOS

2.03e-05440118934244565
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

SPEG SIPA1L3 UBR4 HECTD4 DYRK1A NUP214 PRAG1 LYST CABLES1 PIKFYVE KLF10 MTOR TLN2 PRKDC

2.38e-0511051181435748872
Pubmed

IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.

MYH1 MYH4 MTOR

2.50e-0517118322351927
Pubmed

Phosphoinositide-specific phospholipase C β 1b (PI-PLCβ1b) interactome: affinity purification-mass spectrometry analysis of PI-PLCβ1b with nuclear protein.

KPNA4 FMR1 HMGB3 CNOT1 SLC25A31 RPL18A

2.53e-05169118623665500
Pubmed

Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.

HAUS6 CCDC50 CABLES1 XRN1 CNOT1 PALLD

2.53e-05169118631462741
Pubmed

ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.

MYBBP1A IFIT1 LGALS3 CDH13

2.57e-0550118437001908
Pubmed

The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation.

KPNA4 MYBBP1A HSPA4L UBR4 KIAA1217 PRKDC CNOT1

2.63e-05253118729911972
Pubmed

Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

ZNF510 FAN1 PIKFYVE CNOT1 PALLD

2.64e-05102118510231032
Pubmed

Human transcription factor protein interaction networks.

ARHGAP32 MYBBP1A INO80C HSPA4L RBM33 UBR4 HMGB3 NUP214 NUP205 YEATS2 KLF10 KAT8 TPX2 XRN1 CNOT1 RPL18A

2.72e-0514291181635140242
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

RBM33 NUP214 NUP205 YEATS2 GHITM TPX2 XRN1 CNOT1 TBL2

2.73e-05457118932344865
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

HSPA4L UBR4 DUSP15 NUP214 IDE LGALS3 NUP205 FBXO22 MTOR GHITM XRN1 PRKDC TBL2

2.78e-059741181328675297
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

DENND4A SIPA1L3 UBR4 F5 TLN2 PRKDC PALLD FHIP2B

3.38e-05361118826167880
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

KPNA4 HSPA4L POLA1 UBR4 UBAP1 DNAJB4 HMGB3 IDE NUP205 RAB3GAP1 NUDT5 MTOR PRKDC PRPF39 CNOT1 RPL18A

3.38e-0514551181622863883
Pubmed

Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.

MYH1 MYH4

3.42e-053118226059207
Pubmed

FMR1 and AKT/mTOR signalling pathways: potential functional interactions controlling folliculogenesis in human granulosa cells.

FMR1 MTOR

3.42e-053118228826600
Pubmed

Simultaneous loss of skeletal muscle myosin heavy chain IIx and IIb causes severe skeletal muscle hypoplasia in postnatal mice.

MYH1 MYH4

3.42e-053118236515178
Pubmed

PIKfyve Regulates Vacuole Maturation and Nutrient Recovery following Engulfment.

PIKFYVE MTOR

3.42e-053118227623384
Pubmed

Human carboxylesterases: an update on CES1, CES2 and CES3.

CES1 CES3

3.42e-053118219508181
Pubmed

Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice.

LYST PRKDC

3.42e-05311827717446
Pubmed

PML-RARα enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway.

PRAM1 MTOR

3.42e-053118221673516
Pubmed

Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis.

LYST PRKDC

3.42e-053118235167491
Pubmed

The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation.

ERCC6 FMR1

3.42e-053118225726753
Pubmed

Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy.

LYST PRKDC

3.42e-053118229242210
Pubmed

CD4 positive T helper cells contribute to retinal ganglion cell death in mouse model of ischemia reperfusion injury.

LYST PRKDC

3.42e-053118223792169
Pubmed

Interactions of the scid or beige mutations with the viable motheaten mutation.

LYST PRKDC

3.42e-05311828781712
Pubmed

Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR.

NUP214 MTOR

3.42e-053118224073922
Pubmed

Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.

LYST PRKDC

3.42e-05311828806787
Pubmed

Defective killing of Candida albicans hyphae by neutrophils from beige mice.

LYST PRKDC

3.42e-05311827769315
Pubmed

Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.

ALCAM PRKDC

3.42e-053118227634757
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

MYBBP1A HSPA4L DYRK1A NUP214 TPX2 PRPF39 CNOT1 PALLD RPL18A

4.98e-05494118926831064
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

KPNA4 POLA1 DNAJB4 NUP214 IDE MTOR JRK GHITM JAKMIP1 FASTKD3 NOL8

5.41e-057541181133060197
Pubmed

A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.

KPNA4 POLA1 NUP214 MIOS CNOT1 SLC25A31 JHY

5.48e-05284118729459677
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

HAUS6 MYBBP1A ERCC6 CABLES1 ZC2HC1A KLF10 TPX2 TLN2 PALLD

5.72e-05503118916964243
Pubmed

Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.

MYBBP1A MTOR TPX2 TBL2

6.43e-0563118434718347
Pubmed

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

LYST PRKDC

6.82e-054118210202929
Pubmed

RNF144A, an E3 ubiquitin ligase for DNA-PKcs, promotes apoptosis during DNA damage.

UBE2L3 PRKDC

6.82e-054118224979766
Pubmed

Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation.

LGALS3 PRKDC

6.82e-054118236924493
Pubmed

Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line.

MYH1 MYH4

6.82e-05411821985022
Pubmed

FMRP S499 is phosphorylated independent of mTORC1-S6K1 activity.

FMR1 MTOR

6.82e-054118224806451
Pubmed

The histone chaperone ASF1 regulates the activation of ATM and DNA-PKcs in response to DNA double-strand breaks.

KAT8 PRKDC

6.82e-054118229954236
Pubmed

PARK2 regulates eIF4B-driven lymphomagenesis.

UBE2L3 MTOR

6.82e-054118235105670
Pubmed

Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.

MYH1 MYH4

6.82e-054118211029314
GeneFamilyCarboxylesterases

CES1 CES3

1.92e-045802461
GeneFamilyHelix-turn-helix CENPB type domain containing

TIGD4 JRK

1.46e-0313802533
GeneFamilyMyosin heavy chains

MYH1 MYH4

1.96e-03158021098
GeneFamilyZinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases

ZC2HC1A KAT8

2.23e-031680266
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000

TDRD5 DENND4A ERCC6 FMR1 HSPA4L MYO9A TEX2 POLA1 IDE LYST PIKFYVE BNIP3 MTOR DZIP3 PRKDC SLC25A31 NOL8

2.01e-0682011517gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlasdev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000

TDRD5 MYBBP1A ERCC6 HSPA4L MYO9A TEX2 POLA1 IDE NUP205 FBXO22 MTOR DZIP3 NDUFAF6 PRKDC SLC25A31 NOL8

7.63e-0681011516gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000

TDRD5 ERCC6 FMR1 HSPA4L TEX2 POLA1 IDE NUP205 FBXO22 MTOR DZIP3 NDUFAF6 PRKDC SLC25A31 NOL8

3.77e-0582211515gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1

INO80C POLA1 HMGB3 UPF2 TPX2 DZIP3 CAB39L PRKDC CNOT1 JHY NOL8

4.90e-0546911511Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500

TDRD5 HSPA4L MYO9A PRKDC

5.23e-05381154gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_500
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500

TDRD5 FMR1 HSPA4L TEX2 POLA1 IDE NDUFAF6 PRKDC SLC25A31 NOL8

7.32e-0540611510gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

USP49 HAUS6 INO80C HSPA4L POLA1 CCDC50 HMGB3 NAA35 UPF2 UBE2L3 QPRT PITX2 TPX2 DZIP3 CES3 PRPF39 FDXACB1 ZFP62 FHIP2B NOL8

1.04e-04145911520facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

HAUS6 ERCC6 INO80C POLA1 HMGB3 TPX2 PRKDC PRPF39 CNOT1 JHY NOL8

1.50e-0453211511Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

KPNA4 DENND4A UBR4 UBAP1 DNAJB4 KLF10 ARHGAP20

8.17e-0719211876bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ARHGAP32 CES1 CHST9 LGALS3 KIAA1217 ALCAM PALLD

9.70e-0719711875c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCellsevere-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CES1 GPR84 F5 IFIT1 LGALS3 KLF10 ALCAM

1.07e-062001187a3f22826f3d8f917ff0594bdadd93b60763bcaa2
ToppCell390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells)

USP49 POLA1 UPF2 TPX2 DZIP3 JHY

3.64e-06155118698d8432739965dd1ab77c899cb6321f7f05eaa46
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH1 MYH4 DCDC1 MYO9A CHST9 JHY

8.85e-0618111866956ecd6264f7469a25e555673bce4eb97d28f7a
ToppCellpdx|World / Sample and Cell Type and Tumor Cluster (all cells)

CARMIL1 SIPA1L3 HECTD4 CMIP SCMH1 TLN2

1.03e-051861186de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCellpdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

CARMIL1 SIPA1L3 HECTD4 CMIP SCMH1 TLN2

1.03e-0518611860b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO9A IFIT1 UBE2L3 XRN1 PALLD CDH13

1.10e-0518811866468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO9A IFIT1 UBE2L3 XRN1 PALLD CDH13

1.10e-0518811867a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO9A IFIT1 UBE2L3 XRN1 PALLD CDH13

1.10e-0518811869cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCellnormal_Pleural_Fluid-T/NK_cells-Treg|T/NK_cells / Location, Cell class and cell subclass

CCDC50 F5 LGALS3 NUDT5 ZC2HC1A JAKMIP1

1.17e-051901186519356c4925b5b6647e7d763d4084cd9b2e94f0a
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

DCDC1 CES1 CHST9 DNAH12 ZC2HC1A DZIP3

1.24e-05192118603acd4a26b986e34eee608747347791122f1aa52
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

DCDC1 CES1 CHST9 DNAH12 ZC2HC1A DZIP3

1.24e-05192118631c6046589e2fbb0486fd044c5b128099d37872f
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPA4L HMGB3 CHST9 KLF10 KIAA1217 PALLD

1.27e-051931186739fb2a57772a800a2e94bdd6c71285bb2c162a7
ToppCellCV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster

F5 LGALS3 ZC2HC1A TPX2 SARDH RPL18A

1.39e-051961186f121b009d64704177f73f2da3848f0ad6ed6bf1f
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NUP214 F5 LYST LGALS3 PRAM1 KLF10

1.43e-05197118615bcfe6105c0b508811fb9bba0bc4312fea04f4c
ToppCellCOVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class

CES1 NUP214 F5 IFIT1 LGALS3 KLF10

1.43e-051971186344801997b89bd81d8d5c3c872934de523233a8d
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-051981186cf0fda1a24449cfd8ed56ffc7841d8accb187949
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-0519811867e1f08dae11a7cc7949a5622d82c7e6660d06dea
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-051981186525adc91fd8f2ad957b1879a5bf3950baa7d5ef8
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-05198118670e62d815b2a0aa5327ff94d6f4d503176e007b9
ToppCellCOVID-19_Severe-Myeloid-Classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-051981186dfe92577c7d1e63315c7564d5d99362c6e7d4d46
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-0519811860128d00e6c3f99a026329dd169c0ea5e0e24c59c
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-05198118651c220507bb05aa6338fec494b8ecf4902437708
ToppCellCOVID-19_Severe-Classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.47e-051981186b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8
ToppCellcontrol-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ARHGAP32 CHST9 LGALS3 KIAA1217 ALCAM PALLD

1.56e-052001186f95bbb94e51ac28b1995026c599ec3a34e012916
ToppCellNS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ARHGAP32 CHST9 LGALS3 KIAA1217 ALCAM PALLD

1.56e-052001186d014959891893b6d3854a471fba1dc50c6625a0a
ToppCellCOVID-19-COVID-19_Severe-Myeloid-CD14+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class

CES1 NUP214 F5 LGALS3 PRAM1 KLF10

1.56e-0520011866abee30708572519045e9456dac2017b5308817a
ToppCellcontrol-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MOSPD2 UBR4 NUP214 LGALS3 PRAM1 KLF10

1.56e-052001186b5d197472799cc61d7497faed91ac2564ae4930a
ToppCellcontrol-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MOSPD2 CES1 F5 LYST LGALS3 PRAM1

1.56e-0520011869e3e13a68bc1110fa000ec2d80f4c654ddbce17e
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

MYH1 MYH4 IL17F IFIT1 CDH13

2.08e-051251185d05556ea185c15815a4f8643f1c01185badbeece
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

MYH1 MYH4 IL17F IFIT1 CDH13

2.42e-051291185f83187c0bb06528127b8d2d56674ab1946846951
ToppCellfacs-Lung-Endomucin_-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

F5 LYST LGALS3 PRAM1 TBC1D14

6.18e-0515711852b60de520edf167f5ca790b478557a778435b3d9
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND4A F5 LYST PRAM1 TBC1D14

6.96e-051611185e227f7b711475624cf80e77f235b1783d88d57b4
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND4A F5 LYST PRAM1 TBC1D14

6.96e-0516111858280a029026c272cae9649b27575831b0dd4e242
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYH1 MYH4 CHST9 PRAG1 PITX2

7.60e-051641185382e42701779d12a7948690b3be72d06dd75c8b4
ToppCelldroplet-Marrow-nan-24m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DENND4A HECTD4 UBAP1 DNAJB4 IFIT1

8.28e-05167118554576e9863403d0d5e3046e61db1ad695d88fee4
ToppCell390C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

USP49 POLA1 TPX2 DZIP3 JHY

8.51e-051681185d8f485f8459532a2cb0bef899e6569142cf75685
ToppCellE16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TEX2 POLA1 LGALS3 CABLES1 FAN1

8.75e-051691185305cedbd97059029d7d2a248a8a4b6cfe281aa54
ToppCelldroplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HAUS6 PRAG1 XRN1 JAKMIP1 FDXACB1

8.75e-051691185d721dbb317a88113b4f76688111908d00f23e899
ToppCelldroplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MYBBP1A PRAG1 NUP205 RAB3GAP1 KAT8

9.00e-051701185070d8683d1a5cc7d594ff0453c961a9bf982c2d0
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ARHGAP32 HMGB3 PIKFYVE MIOS NDUFAF6

9.77e-05173118512f779b8dce79431b2d1002ba524dd3f9566aeb0
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INTS6L USP49 SPEG CABLES1 QPRT

9.77e-05173118526bba58f9fb215d1d155504906cd77e8774f6936
ToppCelldroplet-Lung-LUNG-1m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INTS6L USP49 SPEG CABLES1 QPRT

9.77e-05173118569b404e92aad3e6dff67e75466f073f20a71f13f
ToppCellT_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CCDC50 F5 LYST ZC2HC1A KIAA1217

1.06e-04176118556c055488e34605d32562571a2fee621b47c9441
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC35D2 GPR84 F5 PRAM1 TPX2

1.09e-041771185b41e975e8368e2618b015be095efe8c0e001c78b
ToppCellfacs-Marrow-Granulocytes-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC35D2 GPR84 F5 PRAM1 TPX2

1.09e-04177118515d1de38e4f1a0d4a786d83ee92240f44bdff006
ToppCelldroplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERCC6 SIPA1L3 DYRK1A PRKDC NOL8

1.12e-04178118509d2687e0d79f12e90af35fc1c0453d249cf2d19
ToppCellT_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

CCDC50 F5 ZC2HC1A KIAA1217 SARDH

1.12e-041781185e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCellPND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ARHGAP32 POLA1 SIPA1L3 SCMH1 FASTKD3

1.15e-0417911859dea57494d59abd6e8abf34e31faf53462ea0fa0
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells)

F5 NBAS NAA35 MTOR ZFP62

1.15e-041791185f378307eb20f002450c748b7be2289d6db2fcbcb
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ABHD12B CES1 CHST9 DNAH12 PALLD

1.18e-0418011851f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCellCV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster

HAUS6 SLC26A2 POLA1 PHKB JHY

1.34e-0418511851979d189c204f4c2893e3170a514ee7d5523406c
ToppCellControl-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

F5 LYST TLN2 PALLD CDH13

1.37e-04186118592092f11ecce22c14f244e42c499af0822977e6f
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

F5 NBAS NAA35 MTOR ZFP62

1.41e-041871185c8278525b3e1d3f3f4defcaf109cce22dd2e157a
ToppCell356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

F5 NBAS NAA35 MTOR ZFP62

1.48e-04189118599b01893da9f9f7c9528afaffad178285211738b
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ABHD12B CHST9 DNAH12 DZIP3 PALLD

1.48e-041891185b4b93bd10b7e3cc16e54ff73beac230f519c010a
ToppCellCOPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class

CARMIL1 SIPA1L3 CCDC50 PIKFYVE UPF2

1.52e-0419011851e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCellCOVID-19_Severe-Treg|COVID-19_Severe / Disease condition and Cell class

SLC35D2 F5 LGALS3 ZC2HC1A JAKMIP1

1.55e-04191118506fdd76ea13b93e29959c745698b57af6746aaeb
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

KPNA4 DENND4A UBAP1 DNAJB4 KLF10

1.63e-041931185dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP2E1 GPR84 IFIT1 LGALS3

1.69e-041041184fdf4599de8cd4ccf1bd7ede4e7af63d69c108b43
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP2E1 GPR84 IFIT1 LGALS3

1.69e-041041184a3d061170fe49d023ac31dbaeb2b5d2347988078
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass

NUP214 LYST PRAM1 KLF10 RPL18A

1.71e-0419511858861c82129f3ef241b1e9fa4825e4621550cee96
ToppCellfacs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPA4L MYO9A ALCAM SARDH CDH13

1.75e-04196118590edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCellmyeloid-CD14+_Monocyte|World / Lineage and Cell class

CES1 NUP214 LGALS3 PRAM1 KLF10

1.75e-041961185b70f9402a1707671c0dd44226fa2adfc4bde8283
ToppCellfacs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HSPA4L CABLES1 ALCAM SARDH CDH13

1.75e-041961185c936014125b2ed5f796221b74acb77b8f8359875
ToppCellmyeloid|World / Lineage and Cell class

CES1 NUP214 LGALS3 PRAM1 KLF10

1.75e-041961185c76af19827917b9f64ed9fff449f34d04e080a2a
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass

NUP214 LYST PRAM1 KLF10 RPL18A

1.75e-0419611852bc67c2346dfb7732e2e6bb273f3da1c5ee6cf0a
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 CHST9 DNAH12 DZIP3 PALLD

1.79e-04197118591637bdeab85024b5a02d1066f76cb803a2d6420
ToppCellNS-critical-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CES1 CHST9 DNAH12 DZIP3 PALLD

1.79e-04197118562e20ef825b92908d7732aa625dcff7b95ef6ca8
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 CHST9 DNAH12 DZIP3 PALLD

1.79e-04197118522c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 CHST9 DNAH12 DZIP3 PALLD

1.79e-0419711853bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NUP214 LYST LGALS3 PRAM1 KLF10

1.79e-041971185321ccd20b0bb03c99a00452ac3c637ee3aa73ecf
ToppCellPBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

NUP214 LYST LGALS3 PRAM1 KLF10

1.79e-0419711856e96a6c2576f52b72aeab1e41f47a0af05ff327a
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 CHST9 DNAH12 DZIP3 PALLD

1.79e-04197118587db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCellBac-SEP-Myeloid-CD14_Mono|Bac-SEP / Disease, Lineage and Cell Type

CES1 UBR4 NUP214 LGALS3 KLF10

1.79e-041971185d9f1d87ea08139399351db154b63994aa1c9b052
ToppCellPBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NUP214 LYST LGALS3 PRAM1 KLF10

1.79e-041971185a80be1081f3ed0aceea69a33be21bca6bc354472
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NUP214 LYST LGALS3 PRAM1 KLF10

1.79e-041971185928d70af7b990300be69a4debce6e66b556e5d9f
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NUP214 LYST LGALS3 PRAM1 KLF10

1.79e-0419711850050da0d809075fde3a7f17894dbb410b254988c
ToppCellnormal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

NUP214 LYST LGALS3 PRAM1 KLF10

1.84e-04198118558aa5041077fe17ca01c5e6da077d8008d5123ab
ToppCellBLOOD--(3)_Classical_Mono-2| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

NUP214 LYST LGALS3 PRAM1 KLF10

1.84e-04198118534c23181c227f65209cde4382248253282f6ac6e
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NUP214 LYST LGALS3 PRAM1 KLF10

1.84e-0419811854d70995b4dd6365b0c3cda3663a82efdb4870d19
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

NUP214 LYST LGALS3 PRAM1 KLF10

1.84e-0419811852a361af16bf6ecec12f22bdf7926afc7e5ad45ae
ToppCellnormal-na-Myeloid|normal / PBMC cell types (v2) per disease, treatment status, and sex

NUP214 LYST LGALS3 PRAM1 KLF10

1.84e-041981185fd8ab3de94c3dc551f28668317109656fc58e463
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP32 MYO9A SIPA1L3 DYRK1A SCMH1

1.84e-0419811851996373bdccc55aac347d349bd22f6aad6d0c668
ToppCellBLOOD--(3)_MNP| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

NUP214 LYST LGALS3 PRAM1 KLF10

1.84e-0419811854bba020c2bef7f4cc0c9237644f5a39398039286
ToppCellBronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CYP2E1 HMGB3 CHST9 DNAH12 KIAA1217

1.84e-0419811851fe60443c11d34b6d2671af8f06e0dedc8d1558b
ToppCellBronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X

HSPA4L HMGB3 CHST9 ZC2HC1A KIAA1217

1.84e-041981185f5b7013045b61fc56894f80092f799770dde1c8f
ToppCellremission-Classical_Monocyte|World / disease stage, cell group and cell class

NUP214 LYST LGALS3 PRAM1 KLF10

1.84e-041981185056b8745e753b1a500cf58d09a2ebf38707e1357
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ARHGAP32 CHST9 DNAH12 ALCAM PALLD

1.84e-041981185d0ecace1fad24ce50b0935036fabb07e6c9e372d
ToppCell18-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class

CES1 SLC26A2 SPEG PALLD RPL18A

1.88e-0419911859dd130c041beaa319727f9d22b3f45ba0da49487
ToppCellParenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP32 MYO9A SIPA1L3 KIAA1217 ALCAM

1.88e-0419911855cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCellNS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ARHGAP32 CHST9 LGALS3 ALCAM PALLD

1.88e-041991185b88a81cd2a89f4d27100c96ae4324dcee68daf83
ToppCellCOVID-19_Severe-Classical_Monocyte|COVID-19_Severe / Disease condition and Cell class

CES1 F5 LGALS3 KLF10 RPL18A

1.88e-041991185ea1e2ccde3930fab6d04a9bf130837455c742474
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

ARHGAP32 SIPA1L3 DYRK1A NBAS SCMH1

1.88e-04199118594b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCellSepsis-Leuk-UTI-Myeloid-CD14+_Monocyte|Leuk-UTI / Disease, condition lineage and cell class

CES1 UBR4 NUP214 PRAM1 CMIP

1.92e-04200118504d0164b80d424a308ada3fea6bb4a9d6cf686e3
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ARHGAP32 CES1 KIAA1217 ALCAM PALLD

1.92e-04200118597f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellNS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CES1 CHST9 LGALS3 KIAA1217 ALCAM

1.92e-04200118564462a18afca3c1a8548a857924b8166058bf958
ToppCellSepsis-Bac-SEP-Myeloid-CD14+_Monocyte|Bac-SEP / Disease, condition lineage and cell class

CES1 UBR4 NUP214 LGALS3 KLF10

1.92e-0420011851958c32c728a250e08c6313c40e3582dcff564c3
ToppCellTracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SLC26A2 HMGB3 CHST9 KIAA1217 ALCAM

1.92e-042001185efd461c687155c84ef590352207e6fe4ba392a90
ComputationalGenes in the cancer module 97.

NUP205 BNIP3 KLF10 MIOS ALCAM

3.76e-0498685MODULE_97
ComputationalGenes in the cancer module 262.

NUP205 BNIP3 KLF10 MIOS ALCAM

4.13e-04100685MODULE_261
ComputationalGenes in the cancer module 182.

NUP205 BNIP3 KLF10 MIOS ALCAM

4.13e-04100685MODULE_182
ComputationalNeighborhood of TST

CYP2E1 CES1 QPRT SARDH SLC38A3

4.95e-04104685GNF2_TST
Drugcreatine

MYH1 MYH4 SLC35D2 CMIP SARDH PALLD TBL2 SLC25A31

6.71e-061931168CID000000586
DrugMorantel tartrate [26155-31-7]; Down 200; 10.8uM; HL60; HT_HG-U133A

KPNA4 HSPA4L SIPA1L3 UBAP1 IFIT1 PIKFYVE RAB3GAP1 UBE2L3

6.96e-0619411681840_DN
Drugoxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine

HSPA4L UBR4 UBAP1 DNAJB4 BNIP3 UPF2 UBE2L3

7.99e-061411167ctd:C472349
Diseasedistal myopathy (implicated_via_orthology)

MYH1 MYH4 DNAJB4

1.27e-05121163DOID:11720 (implicated_via_orthology)
Diseasecomplex trait

KPNA4 DNAJB4 CABLES1 NBAS UBE2L3 KAT8 TBL2

1.01e-042711167EFO_0010578
Diseaseschizophrenia, intelligence, self reported educational attainment

DENND4A CARMIL1 DNAJB4 LGALS3 NUP205 BNIP3 CDH13

4.49e-043461167EFO_0004337, EFO_0004784, MONDO_0005090
Diseasecolon cancer (biomarker_via_orthology)

CYP2E1 LGALS3 MTOR

4.88e-04391163DOID:219 (biomarker_via_orthology)
Diseasemiddle cerebral artery infarction (biomarker_via_orthology)

ERCC6 CYP2E1 BNIP3 MTOR

5.06e-04931164DOID:3525 (biomarker_via_orthology)
Diseaseautosomal dominant hyaline body myopathy (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:0111269 (implicated_via_orthology)
Diseasedistal arthrogryposis type 2B3 (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:0111602 (implicated_via_orthology)
Diseasedistal arthrogryposis type 1 (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:0111596 (implicated_via_orthology)
Diseasedilated cardiomyopathy 1S (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:0110454 (implicated_via_orthology)
Diseasecongenital myopathy 6 (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:0080719 (implicated_via_orthology)
Diseaseinclusion body myositis (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:3429 (implicated_via_orthology)
Diseasedistal arthrogryposis type 2A (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:0111605 (implicated_via_orthology)
Diseasefamilial hypertrophic cardiomyopathy (implicated_via_orthology)

MYH1 MYH4

6.75e-04101162DOID:0080326 (implicated_via_orthology)
Diseaseuric acid measurement

DCDC1 MYO9A CARMIL1 SIPA1L3 HECTD4 F5 KLF10 NDUFAF6 TBL2

6.98e-046101169EFO_0004761
Diseaseneutrophil percentage of leukocytes

USP49 DENND4A MOSPD2 TEF CMIP ZC2HC1A UBE2L3 TBC1D14 PRKDC

6.98e-046101169EFO_0007990
Diseasemyotonia congenita (implicated_via_orthology)

MYH1 MYH4

9.86e-04121162DOID:2106 (implicated_via_orthology)
Diseaserestrictive cardiomyopathy (implicated_via_orthology)

MYH1 MYH4

1.16e-03131162DOID:397 (implicated_via_orthology)
DiseaseT-cell surface glycoprotein CD3 epsilon chain measurement

F5 PIKFYVE

1.16e-03131162EFO_0802114
DiseaseVitiligo, response to rhododendrol

LGALS3 CDH13

1.16e-03131162EFO_0004208, EFO_0010824
Diseasemean reticulocyte volume

USP49 DYRK1A ZNF510 TEF NUP205 KLF10 MTOR KIAA1217 TPX2 TLN2

1.24e-0379911610EFO_0010701
DiseaseAntithrombotic agent use measurement

HECTD4 F5 PITX2

1.34e-03551163EFO_0009925
Diseasediastolic blood pressure, systolic blood pressure

DCDC1 MYO9A RBM33 SPEG CARMIL1 UBTFL1 CMIP TLN2 CDH13

1.34e-036701169EFO_0006335, EFO_0006336
Diseasealcohol use disorder (biomarker_via_orthology)

CYP2E1 RPL18A

1.35e-03141162DOID:1574 (biomarker_via_orthology)
DiseaseBMI-adjusted adiponectin measurement

CMIP CDH13

1.56e-03151162EFO_0007737
DiseaseIschemic stroke, tissue plasminogen activator measurement

HECTD4 PITX2

1.56e-03151162EFO_0004791, HP_0002140
Diseasedistal arthrogryposis (implicated_via_orthology)

MYH1 MYH4

1.56e-03151162DOID:0050646 (implicated_via_orthology)
DiseaseIschemic stroke, plasminogen activator inhibitor 1 measurement

HECTD4 PITX2

1.77e-03161162EFO_0004792, HP_0002140
Diseasefactor XI measurement, Ischemic stroke

HECTD4 PITX2

2.00e-03171162EFO_0004694, HP_0002140
DiseaseMicrocephaly

ERCC6 DYRK1A NUP214

2.36e-03671163C0025958
Diseasefactor VIII measurement, Ischemic stroke

HECTD4 PITX2

2.51e-03191162EFO_0004630, HP_0002140
Diseasevisual cortical surface area measurement

DCDC1 ALCAM

2.78e-03201162EFO_0004771
DiseaseArthrogryposis

ERCC6 MYO9A

3.06e-03211162C0003886
Diseaseautism spectrum disorder (implicated_via_orthology)

ARHGAP32 FMR1 DYRK1A JAKMIP1

3.10e-031521164DOID:0060041 (implicated_via_orthology)
Diseaseserum gamma-glutamyl transferase measurement

MYO9A SIPA1L3 HECTD4 DYRK1A CCDC50 UBE2L3 NDUFAF6 JAKMIP1 MUC6 TBL2

3.29e-0391411610EFO_0004532
Diseaserenal system measurement, blood urea nitrogen measurement

DCDC1 HECTD4

3.36e-03221162EFO_0004741, EFO_0004742
DiseaseCraniofacial Abnormalities

ERCC6 FMR1 SLC26A2 PITX2

3.40e-031561164C0376634
Diseasetransient cerebral ischemia (biomarker_via_orthology)

ERCC6 FMR1 BNIP3 MTOR

3.48e-031571164DOID:224 (biomarker_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
HKIKFVVSKFPEGLF

TDRD5

301

Q8NAT2
VFKVFVASPHKTQPI

CAB39L

276

Q9H9S4
FAKKAVEKPPQTEHI

CES1

551

P23141
LQEEKKRKKHFPEFP

CCDC50

121

Q8IVM0
LKKPELKIPHTVNFY

ABHD12B

86

Q7Z5M8
PFPKEALAHEKFTKE

CMIP

481

Q8IY22
ITKEPKVFFHKTQLP

C19orf18

51

Q8NEA5
PAHILDQAPKARKFF

DYRK1A

381

Q13627
DPFKFEIHKQAVPDK

CDH13

616

P55290
QPAFGADHDVPKRKK

ERCC6

1041

Q03468
FNDACHKVAKPKEPI

DENND4A

31

Q7Z401
SKVLHFPNPEDKKLE

RAB3GAP1

816

Q15042
PQQRKAIAKFKEPAH

RBM33

1131

Q96EV2
PEKFKPEHFLNENGK

CYP2E1

406

P05181
PKRLHTFGNPFKQDK

INTS6L

576

Q5JSJ4
HKPDFISLFKNPPKN

NUP205

46

Q92621
KIQPFHFIKDPKNLT

FBXO22

186

Q8NEZ5
EGKFLEPHKFAALQK

MUC6

191

Q6W4X9
EPFLNPFKKIKDHLL

DCDC1

241

M0R2J8
TFAPPKQAFDKVLSK

JHY

441

Q6NUN7
VFHPAFTKASPVVKN

GHITM

16

Q9H3K2
LVEEHLKSAQYKKPP

KAT8

421

Q9H7Z6
QLPHAGKFALKIFVK

KY

526

Q8NBH2
KPFKIQVLVEPDHFK

LGALS3

196

P17931
PVDHPVRKLFQKFKQ

KCNH5

701

Q8NCM2
KELAAIAFVKFPPHD

FHIP2B

716

Q86V87
FPVKPHNKSFAHILE

JRK

406

O75564
ALALKHANAKPFEVP

NUDT5

201

Q9UKK9
FHKTVPVKAFPAFLQ

NDUFAF6

276

Q330K2
EFIKKLPFTQHPEIF

DNAH12

2761

Q6ZR08
LPKKEEKHPEIFVNF

NUP214

276

P35658
KPPKKHVVETFFGFD

JAKMIP1

431

Q96N16
FQKPKPAKGKPEAHF

MYH1

566

P12882
PAEFPSAKKNLLKGH

NALF2

176

O75949
FSLKLFAKEVAPVPK

QPRT

281

Q15274
SDFHGPPKKIIKVQK

NOL8

211

Q76FK4
HLFFTNVRPPKKVLE

HECTD4

3296

Q9Y4D8
VKHVKKLPFTKGHFP

ARHGAP32

101

A7KAX9
LKFPLKIFQHSKPDL

NBAS

966

A2RRP1
LALIKHLNVFPAPKK

DZIP3

471

Q86Y13
KPPFQSHFCVVSKPK

POLA1

576

P09884
LIAHPKLFPQVFSAK

GPR84

121

Q9NQS5
PYFHVKPLEKAQLKN

PRPF39

341

Q86UA1
RKIPKVGHTFFQKPE

IL17F

31

Q96PD4
HVCTAKLPKQFKFAP

MYBBP1A

336

Q9BQG0
AAKEAHKPPVFIEKL

PALLD

1226

Q8WX93
CFRKKTHVKFPLNPQ

PLA2G4E

161

Q3MJ16
KAAKPLPFKDPNFVH

INO80C

76

Q6PI98
LDNVNFHIKKPSKYP

PIKFYVE

521

Q9Y2I7
KPKKTPFLVSFFIAQ

SLC25A31

216

Q9H0C2
FHPDKNKSPQAEEKF

DNAJB4

31

Q9UDY4
NPNKPATKDTFHKIK

FMR1

116

Q06787
NIPPKEFLFKHPKRT

BNIP3

126

Q12983
SGSPRPKNFKKIHFI

CABLES1

311

Q8TDN4
PEVPIKKHFKECINF

DUSP15

56

Q9H1R2
PHQLEFIQKFSPKEA

C1orf112

511

Q9NSG2
FLTSFPKQDHPKAKL

LYST

191

Q99698
FKLATKNHKPFSLLP

IFIT1

191

P09914
EHKKKNPEVPVNFAE

HMGB3

26

O15347
PAKKSDPFQKEQDHL

HAUS6

526

Q7Z4H7
AKPHIAAPFKEEEKS

KLF10

126

Q13118
HRKGKEVPPSFKQFF

CARMIL1

406

Q5VZK9
KFKLPTKNEFIPTNF

IDE

521

P14735
HVLNSKKPFDLHIPK

CCDC168

671

Q8NDH2
KELLKEKPFHSVPFL

CES3

326

Q6UWW8
KNFVPGKIEPFKSHS

FDXACB1

516

Q9BRP7
FKQPSKPEIVSKALF

ALCAM

131

Q13740
EFKSFEELEPPKHSK

PHKB

681

Q93100
KVKSAAEKFNLSFPP

UPF2

326

Q9HAU5
AALPPKDFAHKRQKA

MTOR

461

P42345
SPSCKKFKHLFQQLP

FAN1

756

Q9Y2M0
FKKPLSVFKGPLLHI

MOSPD2

316

Q8NHP6
EGNHVKLFPKSKPVA

ARHGAP20

786

Q9P2F6
IHFPDFDKKIPVKLF

SLC35D2

81

Q76EJ3
KSFLQKSPSKEPHFT

SLC38A3

46

Q99624
HFKNKADKPLSIHPQ

F5

101

P12259
HPVNFLAKIFKPLFL

FASTKD3

461

Q14CZ7
FGKLKKFSQPELSEH

PRAM1

41

Q96QH2
VPKSFFSKQPVRNKH

SIPA1L3

1441

O60292
TVPPKEKKNLEFFHE

KIAA1217

1171

Q5T5P2
FNPRKHKFAEEDLKP

TEF

201

Q10587
FQKPKPAKGKPEAHF

MYH4

566

Q9Y623
KFFPRQHPGANEKDK

PITX2

51

Q99697
AVKQFHDSKIKFPLP

RPL18A

141

Q02543
AHLKSPFDPNNKRVK

SARDH

901

Q9UL12
PHLDKKKVQQLPDHF

SCMH1

371

Q96GD3
APKELKFPNFKDRHS

CHST9

386

Q7L1S5
KPAPHLFAQLSKVLK

CNOT1

106

A5YKK6
PKLFAHFKKNNLTPD

TBC1D14

566

Q9P2M4
KQKVLSPPHIKADFN

UBAP1

141

Q9NZ09
FFKKVKFHGEPQKPP

UBTFL1

211

P0CB47
HNSKFKDLIGKEFVP

MIOS

96

Q9NXC5
HKKESKVPPEFDFSA

NAA35

701

Q5VZE5
EFAAKFIPSQAKPKA

SPEG

1626

Q15772
LNEHFKSKLKAPIPI

SLC26A2

321

P50443
APFSKVITFHKKEPF

HSPA4L

426

O95757
KFFPEPSGLHEKRKQ

PHOX2A

76

O14813
FVESFPAHPEVKNLK

TIGD4

286

Q8IY51
FLNLDPSKTEHLFPK

USP49

281

Q70CQ1
STLKIHFELGKPFKP

XRN1

496

Q8IZH2
DLNKGETSFHLKKPF

TRAV16

81

A0A0A6YYK6
SFPEEKAVHKEKPSF

PRAG1

181

Q86YV5
NLHPAKPKDFSAFIN

PRKDC

611

P78527
FFPVALKKHGPICQK

ZC2HC1A

26

Q96GY0
KPTPEFKQQLAAFSK

TLN2

2261

Q9Y4G6
LINHKSVHPGEKPFK

ZFP62

576

Q8NB50
LPKHPKFQTLEQAFE

ZNF510

241

Q9Y2H8
KPPDSKLNLHLFKQF

TEX2

236

Q8IWB9
NPFKAKGLTPKLHVF

ZNF557

111

Q8N988
KLHASKPKNAFLAPA

UBR4

2631

Q5T4S7
VLPIEHKKFGKAFAF

ZNF559

266

Q9BR84
FTATPEDFPKKHKAP

TBL2

176

Q9Y4P3
VFNHPAIKKFLESPS

YEATS2

106

Q9ULM3
PKITFKTKIYHPNID

UBE2L3

66

P68036
FTVNPDLHPKHFKIN

WDR64

691

B1ANS9
SFLDPPHDEKKFKQL

WDR64

846

B1ANS9
LPHFDTINLPEKKVK

TPX2

571

Q9ULW0
FPALLTHPKEKINKE

KPNA4

331

O00629
PELAKKIKIFFALAP

LIPK

186

Q5VXJ0
FKSKPALPKHLLEVN

MYO9A

846

B2RTY4